AC Immune (ACIU) Interest Coverage Ratio (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | AC Immune | 325.88 Mn | 211.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 166.38% |
| Dec 31, 2025 | -197.52% |
| Sep 30, 2025 | -9.37% |
| Jun 30, 2025 | 8.10% |
| Mar 31, 2025 | 163.58% |
| Dec 31, 2024 | -156.13% |
| Sep 30, 2024 | -135.73% |
| Jun 30, 2024 | 207.52% |
| Mar 31, 2024 | -521.00% |
| Dec 31, 2023 | -77.10% |
| Sep 30, 2023 | -5.78% |
| Jun 30, 2023 | 248.53% |
| Mar 31, 2023 | 100.97% |
| Dec 31, 2022 | -10,793.52% |
| Sep 30, 2022 | 10.93% |
| Jun 30, 2022 | 28.90% |
| Mar 31, 2022 | 209.08% |
| Dec 31, 2021 | -64.70% |
| Sep 30, 2021 | 21.12% |
| Jun 30, 2021 | -98.93% |
| Mar 31, 2021 | 1,007.82% |
| Dec 31, 2020 | 90.46% |
| Sep 30, 2020 | 45.94% |
| Jun 30, 2020 | -84.65% |
| Mar 31, 2020 | 152.15% |
| Dec 31, 2019 | 446.34% |
| Sep 30, 2019 | -813.10% |
| Jun 30, 2019 | 100.15% |
| Mar 31, 2019 | -51,447.96% |
| Dec 31, 2018 | -90.05% |
| Sep 30, 2018 | -25.35% |
| Jun 30, 2018 | 160.39% |
| Mar 31, 2018 | -57,014.03% |
| Dec 31, 2017 | -27.12% |
| Sep 30, 2017 | 131.97% |
| Jun 30, 2017 | -236.98% |
| Mar 31, 2017 | 104.67% |
| Dec 31, 2016 | -1,448.80% |
| Mar 31, 2016 | 725.50% |
| Dec 31, 2015 | 164.04% |